Skip to product information
Clinical Research & Data
The following are summaries of independent laboratory and preclinical studies. These materials are for research purposes only.
Emerging Use of BPC-157 in Orthopaedic Sports Medicine
Vasireddi et al., HSS Journal (2025)
Key Findings:
View on PubMed →
BPC-157 10mg
$40.00
FOR RESEARCH USE ONLY. Not for human consumption. These are summaries of published laboratory and preclinical studies only. No therapeutic claims are made.
BPC-157 Research Peptide
BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from a gastric protein. In laboratory and animal models it is studied for its cytoprotective and regenerative properties across multiple tissue types.
Key Properties
| Property | Details |
|---|---|
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular Weight | 1419.55 Da |
| Purity (our batches) | 99.0–99.4% HPLC verified |
| Form | Lyophilized powder (research vials) |
Key Laboratory Research Summaries (2024–2025)
- Musculoskeletal Healing Review (2025) – Robust regenerative and cytoprotective effects observed in preclinical musculoskeletal injury models. PubMed
- Orthopaedic Sports Medicine Systematic Review (2024) – Analysis of 36 studies (1993–2024) showed promotion of healing via upregulation of growth factors in animal models. PubMed
- Multifunctionality & Safety Overview (2025) – Pleiotropic effects noted in tissue injury, gastrointestinal, and CNS preclinical models with desirable safety profile. PubMed
- Human Pilot Safety Data (2025) – Intravenous infusion up to 20 mg was well-tolerated in a small pilot of healthy adults. PubMed
References
- McGuire et al. (2025) – PubMed 40789979
- Vasireddi et al. (2024) – PubMed 40756949
- Józwiak et al. (2025) – PubMed 40005999
- Lee et al. (2025) – PubMed 40131143